Expression and purification of S5<inf>196-272</inf> and S6<inf>200-317</inf> proteins from Tilapia Lake Virus (TiLV) and their potential use as vaccines

Tilapia Lake Virus Disease (TiLVD) is caused by Tilapia Lake Virus (TiLV), and it has a cumulative mortality rate of up to 90% in Nile tilapia (Oreochromis niloticus). TiLV is a negative enveloped single-stranded RNA virus with 10 genomic segments. Segment 5 (S5) and segment 6 (S6) were predicted to...

Full description

Saved in:
Bibliographic Details
Main Authors: A. Lueangyangyuen, S. Senapin, H. T. Dong, S. Unajak, E. Wangkahart, P. Khunrae
Other Authors: Kasetsart University
Format: Article
Published: 2022
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/73459
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University
id th-mahidol.73459
record_format dspace
spelling th-mahidol.734592022-08-04T10:44:08Z Expression and purification of S5<inf>196-272</inf> and S6<inf>200-317</inf> proteins from Tilapia Lake Virus (TiLV) and their potential use as vaccines A. Lueangyangyuen S. Senapin H. T. Dong S. Unajak E. Wangkahart P. Khunrae Kasetsart University Mahidol University Thailand National Center for Genetic Engineering and Biotechnology Asian Institute of Technology Thailand King Mongkut's University of Technology Thonburi Mahasarakham University Biochemistry, Genetics and Molecular Biology Tilapia Lake Virus Disease (TiLVD) is caused by Tilapia Lake Virus (TiLV), and it has a cumulative mortality rate of up to 90% in Nile tilapia (Oreochromis niloticus). TiLV is a negative enveloped single-stranded RNA virus with 10 genomic segments. Segment 5 (S5) and segment 6 (S6) were predicted to include a signaling peptide, suggesting that the encoded proteins of these two segments may exist as part of the virus envelope. Based on bioinformatic predictions, the S5 and S6 proteins in this study were produced, including S527-343, S527-172, S5196-272, S630-317, S630-190, and S6200-317. All proteins were tested for their expression in Escherichia coli. Only S5196-272 and S6200-317 were expressed as soluble and insoluble proteins, respectively. The soluble protein was purified using affinity chromatography, whereas the insoluble protein was solubilized using 6 M urea lysis buffer before purification. Both proteins were further purified using gel filtration chromatography, and the results showed a symmetric peak of both proteins suggested a high degree of uniformity in the conformation of these proteins. Antigenicity results indicated that these proteins were recognized by serum from TiLV-infected fish. The immunization tests revealed that serum antibodies levels in Nile tilapia produced by S5196-272 and S6200-317 were significantly increased (p-value < 0.05) at 7 days post-immunization (dpi) compared to antibody levels on Day 0 (D0). All the results combined suggested a potential vaccine candidate of S5 and S6 for TiLV protection in Nile tilapia. 2022-08-04T03:44:08Z 2022-08-04T03:44:08Z 2022-02-01 Article Protein Expression and Purification. Vol.190, (2022) 10.1016/j.pep.2021.106013 10960279 10465928 2-s2.0-85118901313 https://repository.li.mahidol.ac.th/handle/123456789/73459 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85118901313&origin=inward
institution Mahidol University
building Mahidol University Library
continent Asia
country Thailand
Thailand
content_provider Mahidol University Library
collection Mahidol University Institutional Repository
topic Biochemistry, Genetics and Molecular Biology
spellingShingle Biochemistry, Genetics and Molecular Biology
A. Lueangyangyuen
S. Senapin
H. T. Dong
S. Unajak
E. Wangkahart
P. Khunrae
Expression and purification of S5<inf>196-272</inf> and S6<inf>200-317</inf> proteins from Tilapia Lake Virus (TiLV) and their potential use as vaccines
description Tilapia Lake Virus Disease (TiLVD) is caused by Tilapia Lake Virus (TiLV), and it has a cumulative mortality rate of up to 90% in Nile tilapia (Oreochromis niloticus). TiLV is a negative enveloped single-stranded RNA virus with 10 genomic segments. Segment 5 (S5) and segment 6 (S6) were predicted to include a signaling peptide, suggesting that the encoded proteins of these two segments may exist as part of the virus envelope. Based on bioinformatic predictions, the S5 and S6 proteins in this study were produced, including S527-343, S527-172, S5196-272, S630-317, S630-190, and S6200-317. All proteins were tested for their expression in Escherichia coli. Only S5196-272 and S6200-317 were expressed as soluble and insoluble proteins, respectively. The soluble protein was purified using affinity chromatography, whereas the insoluble protein was solubilized using 6 M urea lysis buffer before purification. Both proteins were further purified using gel filtration chromatography, and the results showed a symmetric peak of both proteins suggested a high degree of uniformity in the conformation of these proteins. Antigenicity results indicated that these proteins were recognized by serum from TiLV-infected fish. The immunization tests revealed that serum antibodies levels in Nile tilapia produced by S5196-272 and S6200-317 were significantly increased (p-value < 0.05) at 7 days post-immunization (dpi) compared to antibody levels on Day 0 (D0). All the results combined suggested a potential vaccine candidate of S5 and S6 for TiLV protection in Nile tilapia.
author2 Kasetsart University
author_facet Kasetsart University
A. Lueangyangyuen
S. Senapin
H. T. Dong
S. Unajak
E. Wangkahart
P. Khunrae
format Article
author A. Lueangyangyuen
S. Senapin
H. T. Dong
S. Unajak
E. Wangkahart
P. Khunrae
author_sort A. Lueangyangyuen
title Expression and purification of S5<inf>196-272</inf> and S6<inf>200-317</inf> proteins from Tilapia Lake Virus (TiLV) and their potential use as vaccines
title_short Expression and purification of S5<inf>196-272</inf> and S6<inf>200-317</inf> proteins from Tilapia Lake Virus (TiLV) and their potential use as vaccines
title_full Expression and purification of S5<inf>196-272</inf> and S6<inf>200-317</inf> proteins from Tilapia Lake Virus (TiLV) and their potential use as vaccines
title_fullStr Expression and purification of S5<inf>196-272</inf> and S6<inf>200-317</inf> proteins from Tilapia Lake Virus (TiLV) and their potential use as vaccines
title_full_unstemmed Expression and purification of S5<inf>196-272</inf> and S6<inf>200-317</inf> proteins from Tilapia Lake Virus (TiLV) and their potential use as vaccines
title_sort expression and purification of s5<inf>196-272</inf> and s6<inf>200-317</inf> proteins from tilapia lake virus (tilv) and their potential use as vaccines
publishDate 2022
url https://repository.li.mahidol.ac.th/handle/123456789/73459
_version_ 1763496724995768320